← Eichor
Study identifier: NCT03947450 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Autologous Volar Fibroblast Injection Into the Stump Site of Amputees

Condition: Amputation · Skin Wound · Stem Cell  ·  Sponsor: Johns Hopkins University

PhasePhase 2
Planned participants50
Who can joinAll sexes, 18 Years to 65 Years
Healthy volunteersYes

About this study

This study is a clinical trial testing the safety and efficacy of volar fibroblast (skin cells from the palm or sole) injections for thickening the epidermal (skin) layer at the stump site in people with below the knee amputations. The study will enroll adults seen at Johns Hopkins.

This description comes directly from the study's public registry record.

Talk to the study team

Ruizhi Wang, MPhil  ·  410-502-7546  ·  rwang53@jhmi.edu

Erika Dare, CRNP  ·  410-502-7546  ·  edare1@jhmi.edu

Always discuss trial participation with your own doctor first.

Locations (1)

Department of Dermatology at Johns Hopkins UniversityBaltimore, Maryland, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT03947450